Before We Start
A vasculitis that targets the coronary arteries
Kawasaki disease is an acute vasculitis (blood vessel inflammation) of unknown cause, almost always affecting children under 5. The real danger isn't the fever or rash, it's that inflammation can damage the coronary arteries themselves, causing aneurysms that put a child at risk for heart attack, even decades later.
Diagnosis
CRASH and Burn — fever plus at least 4 of 5 features
C — Conjunctivitis
Bilateral, without the discharge typically seen in bacterial conjunctivitis.
R — Rash
Polymorphous (varies in appearance), typically on the trunk.
A — Adenopathy
Cervical lymphadenopathy, usually unilateral, at least 1.5 cm.
S — Strawberry tongue
Along with red, cracked lips and diffuse redness of the mouth and throat.
H — Hand/feet swelling
Redness and swelling of the palms and soles acutely, followed by peeling of the fingertips and toes as the child recovers (subacute phase).
Burn — Fever ≥5 days
This is the mandatory criterion, not optional like the other five. Fever is usually high (over 38.5°C/101.3°F) and responds poorly to standard antipyretics like acetaminophen.
💊 Diagnosis requires the fever PLUS at least 4 of the 5 CRASH features. Fewer than 4 features with the fever still present is called "incomplete Kawasaki disease," and may still be diagnosed based on lab findings or a positive echocardiogram.
💡 Memory Trick — The Aspirin Exception
Nursing students are taught, correctly, to avoid aspirin in children because of the risk of Reye's syndrome. Kawasaki disease is the major exception to that rule. High-dose aspirin, alongside IVIG, is standard treatment, because the anti-inflammatory and antiplatelet effects outweigh the Reye's syndrome risk in this specific, serious condition. This exception is a favorite NCLEX trap, know it goes both ways: avoid aspirin in children generally, but Kawasaki disease is the deliberate exception.
Treatment
IVIG and aspirin, ideally within 10 days of fever onset
IVIG (intravenous immunoglobulin) is given as a large single infusion to rapidly reduce systemic inflammation. High-dose aspirin is given alongside it, then reduced to a low, antiplatelet dose once the child has been afebrile for 48 to 72 hours. Treatment within the first 10 days of illness reduces the risk of coronary artery aneurysm from roughly 25% down to 3 to 5%.
Live vaccines should be delayed for about 11 months after IVIG, since IVIG can blunt the vaccine's effectiveness. Every child with Kawasaki disease gets an echocardiogram, both to guide treatment and to monitor the coronary arteries over time, since larger aneurysms carry ongoing lifelong cardiac risk even after the acute illness resolves.
🏥 Kawasaki Disease Scenarios — Apply What You've Learned
Three scenarios. Identify the correct action or the key teaching point.
1
Scenario: A 3-year-old has had a fever over 39°C for 6 days, along with red eyes without discharge, a rash on the trunk, and cracked, red lips.
Correct interpretation: This meets criteria for Kawasaki disease, fever ≥5 days plus at least 3 to 4 CRASH features described. This should be treated urgently with IVIG and aspirin, and an echocardiogram should be obtained.
2
Scenario: A parent asks why their child is being given aspirin, since they've read that children should never receive aspirin.
Correct teaching: Kawasaki disease is a specific, deliberate exception to that general rule. Aspirin's anti-inflammatory and antiplatelet benefits outweigh the Reye's syndrome risk in this condition specifically.
3
Scenario: A child recovering from Kawasaki disease is due for their MMR vaccine 2 months after receiving IVIG.
Correct action: Delay the live vaccine until about 11 months after the IVIG dose, since IVIG can reduce the vaccine's effectiveness if given too soon.
📌 NCLEX Application
NCLEX tests recognition of the CRASH criteria and the aspirin exception heavily.
Rules to know cold:
• Fever ≥5 days plus at least 4 of 5 CRASH features (or fewer with supporting labs/echo) confirms diagnosis
• Kawasaki disease is the deliberate exception to "avoid aspirin in children" (Reye's syndrome)
• Coronary artery aneurysm is the most serious complication — echocardiography is essential
• Treatment within 10 days of fever onset significantly reduces aneurysm risk
• Delay live vaccines for about 11 months after IVIG
Common NCLEX trap: a question describes a child with high fever and asks whether aspirin is appropriate, testing whether the student overgeneralizes the "no aspirin in children" rule without recognizing Kawasaki disease as the named exception.
⚠️ The Trap — Treating Prolonged Fever as "Just a Virus"
Because Kawasaki disease shares symptoms with common viral illnesses (fever, rash, red eyes), it's easy to attribute a young child's five-day fever to "just a virus running its course," especially since most viral fevers do resolve on their own within that window.
The distinguishing clue is the fever's persistence and poor response to antipyretics, combined with the specific CRASH features. Delaying recognition means delaying IVIG and aspirin past the ideal 10-day treatment window, directly increasing the risk of permanent coronary artery damage.
NCLEX angle: "A 2-year-old has had fever for 5 days, unresponsive to acetaminophen, along with red eyes, a rash, and swollen hands. What should the nurse suspect?" → Kawasaki disease, not a routine viral illness — this combination should prompt urgent evaluation.
✓ Quick Self-Test
Answer before checking:
1. What does CRASH and Burn stand for?
2. How many of the 5 CRASH features are required, along with the fever, for diagnosis?
3. Why is aspirin given in Kawasaki disease despite the usual rule against aspirin in children?
4. What is the most serious complication of Kawasaki disease, and how is it monitored?
5. How long should live vaccines be delayed after IVIG treatment?
Answers:
1. Conjunctivitis, Rash, Adenopathy, Strawberry tongue, Hand/feet swelling, and Burn (fever ≥5 days).
2. Fever ≥5 days plus at least 4 of the 5 CRASH features (fewer may still qualify with supporting labs or echocardiogram findings).
3. Aspirin's anti-inflammatory and antiplatelet effects meaningfully reduce coronary artery aneurysm risk in Kawasaki disease, outweighing the Reye's syndrome concern in this specific condition.
4. Coronary artery aneurysm — monitored with echocardiography, both at diagnosis and over time.
5. About 11 months, since IVIG can reduce the vaccine's effectiveness if given too soon after.
→